Poland· PL-100477133
Doxafin duo
A doxazosin und finasterid product containing doxazosinum + finasteridum, registered in Poland by MIP Pharma GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Doxazosinum + Finasteridum
- Manufacturer
- MIP Pharma GmbH
- Country
- Poland (PL)
- ATC code
- G04CA55
- ATC class
- Doxazosin und Finasterid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991580438
- gtin05909991580445
- gtin05909991580452
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Doxazosin und finasterid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Doxazosin/Finasterid Mip
- Bulgaria · Доксазозин/Финастерид Mip
- Germany · Cardular Duo, Doxa-Fin
- Croatia · Doksazosin/Finasterid Mip
- Italy · Doxazosina E Finasteride Mylan, Finarand
- Romania · Doxazosin/Finasteridă Mip
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/86b2031b-3ecf-4bac-b5de-4ae3c6ccc0c2 GET /v1/drugs/86b2031b-3ecf-4bac-b5de-4ae3c6ccc0c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "4 mg + 5 mg",
"packaging": "05909991580438 ¦ Rp ¦ 162846\n10 tabl.\n05909991580445 ¦ Rp ¦ 162847\n30 tabl.\n05909991580452 ¦ Rp ¦ 162848\n90 tabl.",
"substance": "Doxazosinum 4 mg + Finasteridum 5 mg",
"common_name": "Doxazosinum + Finasteridum",
"pl_product_id": "100477133",
"pozwolenie_nr": "29171",
"auth_procedure": "DCP",
"authorisation_validity": "2030-07-04"
}See everything about doxazosin und finasterid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.